OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-09-01 to 2023-09-01.)

Article	Citations
Deep learning in ophthalmology: The technical and clinical considerations	248
Central serous chorioretinopathy: Towards an evidence-based treatment guideline	217
Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective	187
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration	184
The cell biology of the retinal pigment epithelium	160
Corneal nerves in health and disease	140
Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations	136
Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation	132
Inflammation in Glaucoma: From the back to the front of the eye, and beyond	116
Retinal stem cell transplantation: Balancing safety and potential	113
Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives	111
Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index	111
Uveal melanoma: Towards a molecular understanding	109
Scleral structure and biomechanics	108
Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”	105
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders	98
Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities	98
Efficacy in myopia control	95
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities	90
Immune privilege in corneal transplantation	89
Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)	84
Persistent remodeling and neurodegeneration in late-stage retinal degeneration	81
Age-related macular degeneration: A two-level model hypothesis	79
VEGFR1 signaling in retinal angiogenesis and microinflammation	78
Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis	77

Cell types and cell circuits in human and non-human primate retina	75
Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety	74
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications	74
Cellular mechanisms of hereditary photoreceptor degeneration – Focus on cGMP	73
Cholinergic nervous system and glaucoma: From basic science to clinical applications	69
Interactions of the choroid, Bruch's membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier	65
Advances in the diagnosis and treatment of dry eye	64
Posterior capsule opacification: What's in the bag?	60
Early and late stage gene therapy interventions for inherited retinal degenerations	59
Interpretation of OCT and OCTA images from a histological approach: Clinical and experimental implications	59
Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis	58
Contact lens-related corneal infection: Intrinsic resistance and its compromise	57
Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography	56
Photoreceptor cells and RPE contribute to the development of diabetic retinopathy	56
Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina	55
Inducible rodent models of glaucoma	54
Axon injury signaling and compartmentalized injury response in glaucoma	54
Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses	54
Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances	53
Corneal endothelial dysfunction: Evolving understanding and treatment options	53
Extracellular vesicle therapy for retinal diseases	52
Optic nerve head anatomy in myopia and glaucoma, including parapapillary zones alpha, beta, gamma and delta: Histology and clinical features	50
Innate immune response in retinal homeostasis and inflammatory disorders	49
Normal and glaucomatous outflow regulation	49
The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies	48
Fundus autofluorescence imaging	43
Past, present and future role of retinal imaging in neurodegenerative disease	43
Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections	42
Voltage- and calcium-gated ion channels of neurons in the vertebrate retina	42
Adaptive responses to neurodegenerative stress in glaucoma	42
Uncoupling proteins in the mitochondrial defense against oxidative stress	41
Human limbal epithelial stem cell regulation, bioengineering and function	40
Artificial intelligence in OCT angiography	40
Discovery and clinical translation of novel glaucoma biomarkers	39
Targets of immunomodulation in bacterial endophthalmitis	39
Lessons learned from quantitative fundus autofluorescence	39
Retinal energy metabolism in health and glaucoma	39
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases	39
Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets	39